Shorts On Watch: Is Buying Biolife Solutions Incorporated (NASDAQ:BLFS), Having Higher Short Interest a Winning Strategy?

November 25, 2016 - By Marie Mckinney   ·   0 Comments

Shorts On Watch: Is Buying Biolife Solutions Incorporated (NASDAQ:BLFS), Having Higher Short Interest a Winning Strategy?

The stock of Biolife Solutions Incorporated (NASDAQ:BLFS) registered an increase of 13.05% in short interest. BLFS’s total short interest was 188,800 shares in November as published by FINRA. Its up 13.05% from 167,000 shares, reported previously. With 35,300 shares average volume, it will take short sellers 5 days to cover their BLFS’s short positions. The short interest to Biolife Solutions Incorporated’s float is 2.98%. The stock increased 5.10% or $0.08 on November 25, hitting $1.65. About 21,097 shares traded hands. BioLife Solutions Inc (NASDAQ:BLFS) has declined 15.59% since April 22, 2016 and is downtrending. It has underperformed by 21.00% the S&P500.

BioLife Solutions, Inc. is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The company has a market cap of $20.85 million. The Company’s product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. It currently has negative earnings.

Insitutional Activity: The institutional sentiment decreased to 1.5 in 2016 Q2. Its down 0.17, from 1.67 in 2016Q1. The ratio turned negative, as 3 funds sold all BioLife Solutions Inc shares owned while 0 reduced positions. 2 funds bought stakes while 3 increased positions. They now own 377,414 shares or 5.82% more from 356,666 shares in 2016Q1.
Citadel Advsrs Limited Co holds 0% of its portfolio in BioLife Solutions Inc (NASDAQ:BLFS) for 18,785 shares. The Minnesota-based Perkins Mngmt has invested 0.02% in BioLife Solutions Inc (NASDAQ:BLFS). Deutsche Bankshares Ag has invested 0% of its portfolio in BioLife Solutions Inc (NASDAQ:BLFS). Two Sigma Lc owns 13,141 shares or 0.01% of their US portfolio. The Pennsylvania-based Vanguard Group Inc Inc has invested 0% in BioLife Solutions Inc (NASDAQ:BLFS). Blackrock Institutional Na has invested 0% of its portfolio in BioLife Solutions Inc (NASDAQ:BLFS). Hudock Cap Group Llc last reported 43 shares in the company. Creative Planning holds 143 shares or 0% of its portfolio. Fincl Bank Of America De holds 0% of its portfolio in BioLife Solutions Inc (NASDAQ:BLFS) for 37 shares. Pnc Fincl Services Gp reported 10,000 shares or 0% of all its holdings. Community Bank & Trust Na has invested 0% of its portfolio in BioLife Solutions Inc (NASDAQ:BLFS). Blackrock Fund Advsr accumulated 0% or 1,785 shares. Royal National Bank & Trust Of Canada has 0% invested in the company for 72 shares. Credit Suisse Ag holds 0% or 220,548 shares in its portfolio.

BLFS Company Profile

BioLife Solutions, Inc. (BioLife), incorporated on March 25, 1998, is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage, and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company’s product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products.

More notable recent BioLife Solutions Inc (NASDAQ:BLFS) news were published by: Bizjournals.com which released: “Biolife Solutions posts record Q3 revenue” on November 14, 2016, also Prnewswire.com with their article: “BioLife Solutions to Report Third Quarter 2016 Financial Results and Provide …” published on November 03, 2016, Prnewswire.com published: “BioLife Solutions’ CryoStor® Embedded in Manufacturing Process for Promethera …” on September 15, 2016. More interesting news about BioLife Solutions Inc (NASDAQ:BLFS) were released by: Prnewswire.com and their article: “BioLife Solutions Names Cord Blood Industry Veteran Karen Foster Vice …” published on April 04, 2016 as well as Prnewswire.com‘s news article titled: “BioLife Solutions Executes 10 Year Supply Agreement with Bellicum …” with publication date: August 10, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Marie Mckinney

Tags: , ,


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>